Tag Archives: Biotechnology

Dyne Therapeutics CSO sells shares worth over $80,000, a move that has sparked curiosity and raised eyebrows in the biotechnology world. The Chief Scientific Officer (CSO) of a company like Dyne Therapeutics, responsible for leading the research and development of innovative therapies, holds a pivotal role in shaping its future. …

Dyne Therapeutics SVP sells shares worth over $48,000, a move that has sparked curiosity and speculation within the biotechnology industry. The recent transaction, involving a senior executive at the leading gene therapy company, raises questions about potential motivations and implications for both the company and its investors. The sale, which …

CAMP4 Therapeutics Files for Proposed IPO, signaling a significant step forward for the company and the potential for substantial growth in the pharmaceutical and biotechnology industry. This move marks a pivotal moment for CAMP4, allowing them to access capital to further develop their innovative therapeutic candidates and expand their reach …

Vera Therapeutics director sells over $696k in company stock, a move that has sent ripples through the financial world. This significant transaction has sparked a wave of questions and speculation about the company’s future prospects. While insider stock sales are a common occurrence, the magnitude of this particular transaction has …

Verastem CEO sells shares worth $513 to cover tax obligations, a move that has sparked curiosity and speculation within the financial community. This strategic decision by the CEO, a key figure in the biotechnology industry, has raised questions about Verastem’s financial standing and future prospects. Verastem, a company focused on …

Biolife solutions exec sells over 0k in stock, buys shares at .06 – Biolife Solutions Exec Sells Stock, Buys Shares at $2.06: A high-ranking executive at BioLife Solutions, a leading player in the biotechnology industry, has made a significant move in the stock market. The executive sold over $490,000 worth …

Third Harmonic Bio executive sells over $140k in stock, a move that has sparked curiosity and speculation within the financial community. This significant transaction, executed by a key figure within the company, raises questions about the executive’s motivations, the potential impact on the company’s stock price, and the broader implications …

Verastem director sells shares worth 5 to meet tax obligations – Verastem director sells shares worth $365 million to meet tax obligations, a move that has sent ripples through the pharmaceutical industry. This transaction, involving a significant number of shares, has sparked speculation about the company’s future prospects and the …

Immunome CFO sells shares valued at over $230,000 sets the stage for this enthralling narrative, offering readers a glimpse into a story that is rich in detail and brimming with originality from the outset. The recent transaction, involving the sale of shares worth over $230,000 by Immunome’s Chief Financial Officer, …